{"id":5591,"date":"2016-06-16T00:00:00","date_gmt":"2016-06-15T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/en\/blog\/2020\/05\/01\/the-pi3k-protein-a-potential-new-therapeutic-target-in-pancreatic-neuroendocrine-tumors\/"},"modified":"2020-05-15T21:17:33","modified_gmt":"2020-05-15T19:17:33","slug":"the-pi3k-protein-a-potential-new-therapeutic-target-in-pancreatic-neuroendocrine-tumors","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2016\/06\/the-pi3k-protein-a-potential-new-therapeutic-target-in-pancreatic-neuroendocrine-tumors\/","title":{"rendered":"The PI3K protein: a potential new therapeutic target in pancreatic neuroendocrine tumors"},"content":{"rendered":"

Researchers from the \u2018Angiogenesis signaling pathways\u2019 research group of the Institute of Biomedical Investigation of Bellvitge (IDIBELL), led by Dr. Mariona Graupera, have unveiled the potential therapeutic benefit of a selective inhibitior of the PI3-kinase protein in pancreatic neuroendocrine tumors (PanNETs). The study, published in the Clinical Cancer Research<\/em> journal, provides a significant advance in understanding the role of PI3K signaling in cancer and opens new therapeutic opportunities for this and other types of cancer.<\/p>\n

Pancreatic neuroendocrine tumors, often referred to as “islet cell tumors” are a type of cancer that arises from hormone-releasing cells in the pancreas. They account for less than 2 percent of new pancreatic cancer cases. Over the past 2 decades, few effective treatments for this cancer type have been identified, as PanNETs\u2019 heterogeneity has complicated the design of targeted therapies.<\/p>\n

It is known that mutations in the PI3-kinase (PI3K) protein signaling pathway occur in 16% of patients with PanNETs; in the present study, the researchers assessed the frequency of PI3K pathway activation in 40 human tumor samples<\/p>\n

and in a mice model of PanNETs, and they investigated the therapeutic efficacy of inhibiting this pathway in mice using PI3K generic and isoform-specific inhibitors.<\/p>\n

Dr. Graupera\u2019s team found that either genetic or pharmacological inhibition of only one specific PI3K isoform, called p110\u03b1, is enough to induce tumor cell death and compromises vessel growth, which blocks tumor progression and metastasis. This is particularly relevant given that isoform-selective inhibitors are likely to exhibit lower toxicity compared to generic inhibitors, and therefore higher drug doses that are capable of achieving complete inhibition of the pathway may be tolerated.<\/p>\n

These results not only show promise on a new targeted therapy to treat this malignancy, as PI3K inhibitors are already used in the clinical practice, but also unravel a new function of the PI3K kinase in cancer biology through its role in promoting metastasis. The research group will now focuse on comparing the efficacy of this therapy with other targeted therapies in patients with PI3K mutations.<\/p>\n","protected":false},"excerpt":{"rendered":"

Researchers from the Institute of Biomedical Investigation of Bellvitge (IDIBELL) have demonstrated that selective inactivation of the p110\u03b1 PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs.<\/p>\n","protected":false},"author":6,"featured_media":7841,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[294],"tags":[],"class_list":["post-5591","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vascular-biology-and-signalling"],"publishpress_future_action":{"enabled":false,"date":"2024-09-14 18:56:03","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/5591"}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=5591"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/5591\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/7841"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=5591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=5591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=5591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}